Mesalazine Regulates <i>DUSP1</i>, <i>DUSP4</i>, and <i>DUSP5</i> Expression in Colorectal Cancer: In Vitro and Bioinformatic Evidence.

Madej M, Nowak I, Strzałka-Mrozik B, Kimsa-Dudek M, Kruszniewska-Rajs C, Gola JM.

Open source

DOI
10.3390/pharmaceutics18010029
Published
2025-12-25
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18010029,
  title = {Mesalazine Regulates <i>DUSP1</i>, <i>DUSP4</i>, and <i>DUSP5</i> Expression in Colorectal Cancer: In Vitro and Bioinformatic Evidence.},
  author = {Madej M and  Nowak I and  Strzałka-Mrozik B and  Kimsa-Dudek M and  Kruszniewska-Rajs C and  Gola JM.},
  year = {2025},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18010029},
  url = {https://doi.org/10.3390/pharmaceutics18010029}
}

RIS

TY  - JOUR
TI  - Mesalazine Regulates <i>DUSP1</i>, <i>DUSP4</i>, and <i>DUSP5</i> Expression in Colorectal Cancer: In Vitro and Bioinformatic Evidence.
AU  - Madej M
AU  -  Nowak I
AU  -  Strzałka-Mrozik B
AU  -  Kimsa-Dudek M
AU  -  Kruszniewska-Rajs C
AU  -  Gola JM.
PY  - 2025
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18010029
UR  - https://doi.org/10.3390/pharmaceutics18010029
ER  - 

APA

M, M., I, N., B, S., M, K., C, K., & JM., G. (2025). Mesalazine Regulates <i>DUSP1</i>, <i>DUSP4</i>, and <i>DUSP5</i> Expression in Colorectal Cancer: In Vitro and Bioinformatic Evidence.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18010029

Source records